$JOE

Billionaire Bruce Berkowitz Reveals 76% Of Fairholme Capital Is in Just 1 Stock

Fairholme Capital's Q2 2026 filing shows 76% of its portfolio in St. Joe Company (JOE), with JOE reporting record Q2 revenue and net income growth. Fairholme also opened positions in Pfizer (PFE), Campbell Soup, and UPS, and added to Berkshire Hathaway (BRK-B) and Progressive (PGR).

Original reporting
Published Aug 19, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Billionaire Bruce Berkowitz Reveals 76% Of Fairholme Capital Is in Just 1 Stock — source image
Decision brief

The 30-second read

$JOEBullishMed
01

Why it matters

The filing provides fresh insight into fund allocation, indicating strong conviction in JOE and modest diversification.

02

Market read

Fund concentration and new holdings may influence short‑term price action in the listed stocks.

03

What to watch

Potential regulatory or environmental risks to Florida land development.

Relevance 6/10Novelty 6/10Timing: post‑Q2 earnings release

Background

Fairholme Capital's Q2 2026 13F filing reveals its portfolio composition and new positions.

Company-level read

Ticker impact

$JOEBullishHigh confidence
Context

13F filing shows Fairholme holds 76% of its portfolio in JOE and reports record Q2 revenue.

Expected impact

potential upside as fund adds to buying pressure

Evidence & confidence

Fairholme's sizable stake and Q2 beat suggest strong near‑term support.

$PFEBullishMedium confidence
Context

Fairholme opened a new position of 231,000 Pfizer shares valued at $5.56 M.

Expected impact

small upward pressure

Evidence & confidence

Entry size is modest relative to market float.

$UPSNeutralLow confidence
Context

Fairholme added 23,800 UPS shares valued at $2.56 M.

Expected impact

minimal effect

Evidence & confidence

Position size is small compared with daily volume.

$PGRBullishMedium confidence
Context

Fairholme increased its holding in Progressive (PGR).

Expected impact

slight upside

Evidence & confidence

Adds to existing exposure, but no size disclosed.

$BRK-BNeutralLow confidence
Context

Fairholme added to its Berkshire Hathaway (BRK-B) position.

Expected impact

no material impact

Evidence & confidence

BRK-B is highly liquid; small addition is immaterial.

Market effects

Highlights value‑oriented fund activity in real‑estate and consumer staples.

Northwest Florida land development exposure may attract regional investors.

Limited to US equity markets and fund‑flow dynamics.

Counterpoint

Concentration risk could backfire if JOE faces a downturn.

Key entities

  • Fairholme Capital

    Value‑focused investment firm led by Bruce Berkowitz.

  • St. Joe Company

    Northwest Florida land developer reporting record Q2 results.

Related articles

$BRK-BHighAI 9/10

After Warren Buffett’s Successor’s Q1 Purge, Just 4 Stocks Make Up Over 50% of Berkshire Hathaway

Berkshire Hathaway's new CEO, Greg Abel, reduced the portfolio to 26 stocks in Q1 2026, with Apple (AAPL), American Express (AXP), Coca-Cola (KO), and Bank of America (BAC) making up 53.8% of the portfolio. Abel acquired homebuilder Taylor Morrison (TMHC) for $6.8B at a 24% premium. Analysts rate these four stocks as Buy with price targets and dividend yields noted. Warren Buffett stepped down as CEO but remains chair.

$PFEMedAI 8/10

PFE Looks 4.4% Overvalued on GF Value™ Amid Strong Dividend Fund

Pfizer (PFE) and BioNTech received Health Canada authorization for their updated COVID-19 vaccine targeting the Omicron XFG variant. The company offers a 6.21% dividend yield with a 56% payout ratio and a 2.4% 3-year dividend growth rate. Pfizer's GF Value™ is $26.46, slightly below its market price of $27.64, indicating a 4.4% overvaluation. The company's GF Score™ is 75/100, reflecting strong profitability and momentum but moderate growth and financial strength.

$UPSLow

UPS reshuffles leadership as it moves to global operating model

UPS is reorganizing its senior leadership and adopting a global operating structure, effective September 1. Kate Gutmann will retire but remain as an adviser until March 2027. Wilfredo Ramos will succeed her, overseeing International, Healthcare, and Supply Chain Solutions. The changes follow the completion of UPS's Amazon volume reduction and network restructuring initiatives in June.

$PFEMedAI 8/10

Why Is Pfizer Stock Paying You So Much To Wait?

Pfizer (PFE) generates 7.0% free cash flow yield, higher than the S&P 500 median. It maintains a 6.2% dividend yield, supported by strong margins. Revenue has declined, but non-COVID products grew 5% in Q2. Management targets $9.7B in savings by 2029. The stock trades at 36.5x earnings, with growth dependent on newer products. PFE returned 20.7% over the past year, 4% below its two-year high.